Hämatrain - Effects of hybrid movement therapy on physical and psychological parameters during inpatient and outpatient hematological treatment

Not Applicable

• Conditions: C81.0; C91.0; Nodular lymphocyte predominant Hodgkin lymphoma; Acute lymphoblastic leukaemia [ALL]

• Registration Number: DRKS00034396
• Lead Sponsor: niversitäres Cancer Center Schleswig-Holstein

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2024-04-30
• Study Start: 2024-06-07
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 53

Inclusion Criteria

Haematological disease treated with drug-based tumour therapy
Treatment with a first-line therapy (first-line therapy)

Exclusion Criteria

Serious cardiac diseases (e.g. heart failure NYHA III, myocardial infarction <3 months)
Severe infection or sepsis CTCAE v5 > III
Severe pulmonary global insufficiency
Renal insufficiency (GFR <30% with Crea >3mg/dl)
Severe neurological disorders
No access to independent exercise therapy due to lack of technical skills (no e-mail address etc.)
Thrombocytopenia below 10,000/µl

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
muscle strength: manual force measurement<br>cardiac performence: ergometry (WHO-Scheme)<br>The time until the first complete remission is achieved serves as a run-in phase in which patients receive two supervised training sessions in the first week. After achieving the first complete remission (CR), the first measurement is carried out, in which strength, endurance, quality of life and fatigue are determined with the help of tests and standardised questionnaires. A second measurement takes place 12 weeks after achieving the first complete remission, during which the patients complete the training programme twice a week on their own.

Secondary Outcome Measures

Name	Time	Method
quality of life: EORTC Questionnaire<br>fatigue: MFI-20 Questionnaire<br>The time until the first complete remission is achieved serves as a run-in phase in which patients receive two supervised training sessions in the first week. After achieving the first complete remission (CR), the first measurement is carried out, in which strength, endurance, quality of life and fatigue are determined with the help of tests and standardised questionnaires. A second measurement takes place 12 weeks after achieving the first complete remission, during which the patients complete the training programme twice a week on their own.